Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease
Identifieur interne :
002F99 ( PascalFrancis/Curation );
précédent :
002F98;
suivant :
003000
Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease
Auteurs : D. Bravi [
États-Unis] ;
J. J. Anderson ;
F. Dagani ;
T. L. Davis ;
R. Feerari ;
M. Gillespie ;
T. N. ChaseSource :
-
Movement disorders [ 0885-3185 ] ; 1992.
RBID : Pascal:92-0467065
Descripteurs français
- Pascal (Inist)
- Parkinson maladie,
Exploration,
Traitement,
Homme,
Age,
Consommation oxygène,
Chimiothérapie,
Stimulant dopaminergique,
Mitochondrie,
Thrombocyte,
Chaîne respiratoire.
- Wicri :
English descriptors
- KwdEn :
- Age,
Chemotherapy,
Dopamine agonist,
Exploration,
Human,
Mitochondria,
Oxygen consumption,
Parkinson disease,
Platelet,
Respiratory chain,
Treatment.
| pA |
| A01 | 01 | 1 | | @0 0885-3185 |
|---|
| A03 | | 1 | | @0 Mov. disord. |
|---|
| A05 | | | | @2 7 |
|---|
| A06 | | | | @2 3 |
|---|
| A08 | 01 | 1 | ENG | @1 Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease |
|---|
| A11 | 01 | 1 | | @1 BRAVI (D.) |
|---|
| A11 | 02 | 1 | | @1 ANDERSON (J. J.) |
|---|
| A11 | 03 | 1 | | @1 DAGANI (F.) |
|---|
| A11 | 04 | 1 | | @1 DAVIS (T. L.) |
|---|
| A11 | 05 | 1 | | @1 FEERARI (R.) |
|---|
| A11 | 06 | 1 | | @1 GILLESPIE (M.) |
|---|
| A11 | 07 | 1 | | @1 CHASE (T. N.) |
|---|
| A14 | 01 | | | @1 NINDS NIH, experimental therapeutics branch @2 Bethesda MD 20892 @3 USA |
|---|
| A20 | | | | @1 228-231 |
|---|
| A21 | | | | @1 1992 |
|---|
| A23 | 01 | | | @0 ENG |
|---|
| A43 | 01 | | | @1 INIST @2 20953 @5 354000028971070060 |
|---|
| A44 | | | | @0 0000 |
|---|
| A45 | | | | @0 24 ref. |
|---|
| A47 | 01 | 1 | | @0 92-0467065 |
|---|
| A60 | | | | @1 P |
|---|
| A61 | | | | @0 A |
|---|
| A64 | | 1 | | @0 Movement disorders |
|---|
| A66 | 01 | | | @0 USA |
|---|
| C02 | 01 | X | | @0 002B17G |
|---|
| C03 | 01 | X | FRE | @0 Parkinson maladie |
|---|
| C03 | 01 | X | ENG | @0 Parkinson disease |
|---|
| C03 | 01 | X | SPA | @0 Parkinson enfermedad |
|---|
| C03 | 02 | X | FRE | @0 Exploration |
|---|
| C03 | 02 | X | ENG | @0 Exploration |
|---|
| C03 | 02 | X | SPA | @0 Exploración |
|---|
| C03 | 03 | X | FRE | @0 Traitement |
|---|
| C03 | 03 | X | ENG | @0 Treatment |
|---|
| C03 | 03 | X | GER | @0 Aufbereiten |
|---|
| C03 | 03 | X | SPA | @0 Tratamiento |
|---|
| C03 | 04 | X | FRE | @0 Homme |
|---|
| C03 | 04 | X | ENG | @0 Human |
|---|
| C03 | 04 | X | SPA | @0 Hombre |
|---|
| C03 | 05 | X | FRE | @0 Age |
|---|
| C03 | 05 | X | ENG | @0 Age |
|---|
| C03 | 05 | X | SPA | @0 Edad |
|---|
| C03 | 06 | X | FRE | @0 Consommation oxygène |
|---|
| C03 | 06 | X | ENG | @0 Oxygen consumption |
|---|
| C03 | 06 | X | SPA | @0 Consumo oxígeno |
|---|
| C03 | 07 | X | FRE | @0 Chimiothérapie |
|---|
| C03 | 07 | X | ENG | @0 Chemotherapy |
|---|
| C03 | 07 | X | SPA | @0 Quimioterapia |
|---|
| C03 | 08 | X | FRE | @0 Stimulant dopaminergique |
|---|
| C03 | 08 | X | ENG | @0 Dopamine agonist |
|---|
| C03 | 08 | X | SPA | @0 Estimulante dopaminérgico |
|---|
| C03 | 09 | X | FRE | @0 Mitochondrie |
|---|
| C03 | 09 | X | ENG | @0 Mitochondria |
|---|
| C03 | 09 | X | SPA | @0 Mitocondria |
|---|
| C03 | 10 | X | FRE | @0 Thrombocyte |
|---|
| C03 | 10 | X | ENG | @0 Platelet |
|---|
| C03 | 10 | X | SPA | @0 Trombocito |
|---|
| C03 | 11 | X | FRE | @0 Chaîne respiratoire |
|---|
| C03 | 11 | X | ENG | @0 Respiratory chain |
|---|
| C03 | 11 | X | SPA | @0 Cadena respiratoria |
|---|
| C07 | 01 | X | FRE | @0 Système nerveux pathologie |
|---|
| C07 | 01 | X | ENG | @0 Nervous system diseases |
|---|
| C07 | 01 | X | SPA | @0 Sistema nervioso patología |
|---|
| N21 | | | | @1 275 |
|---|
|
|---|
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003825
Links to Exploration step
Pascal:92-0467065
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease</title>
<author><name sortKey="Bravi, D" sort="Bravi, D" uniqKey="Bravi D" first="D." last="Bravi">D. Bravi</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>NINDS NIH, experimental therapeutics branch</s1>
<s2>Bethesda MD 20892</s2>
<s3>USA</s3>
</inist:fA14><country>États-Unis</country>
</affiliation><author><name sortKey="Anderson, J J" sort="Anderson, J J" uniqKey="Anderson J" first="J. J." last="Anderson">J. J. Anderson</name>
</author><author><name sortKey="Dagani, F" sort="Dagani, F" uniqKey="Dagani F" first="F." last="Dagani">F. Dagani</name>
</author><author><name sortKey="Davis, T L" sort="Davis, T L" uniqKey="Davis T" first="T. L." last="Davis">T. L. Davis</name>
</author><author><name sortKey="Feerari, R" sort="Feerari, R" uniqKey="Feerari R" first="R." last="Feerari">R. Feerari</name>
</author><author><name sortKey="Gillespie, M" sort="Gillespie, M" uniqKey="Gillespie M" first="M." last="Gillespie">M. Gillespie</name>
</author><author><name sortKey="Chase, T N" sort="Chase, T N" uniqKey="Chase T" first="T. N." last="Chase">T. N. Chase</name>
</author><publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">92-0467065</idno>
<date when="1992">1992</date>
<idno type="stanalyst">PASCAL 92-0467065 INIST</idno>
<idno type="RBID">Pascal:92-0467065</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">003825</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002F99</idno>
</publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease</title>
<author><name sortKey="Bravi, D" sort="Bravi, D" uniqKey="Bravi D" first="D." last="Bravi">D. Bravi</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>NINDS NIH, experimental therapeutics branch</s1>
<s2>Bethesda MD 20892</s2>
<s3>USA</s3>
</inist:fA14><country>États-Unis</country>
</affiliation><author><name sortKey="Anderson, J J" sort="Anderson, J J" uniqKey="Anderson J" first="J. J." last="Anderson">J. J. Anderson</name>
</author><author><name sortKey="Dagani, F" sort="Dagani, F" uniqKey="Dagani F" first="F." last="Dagani">F. Dagani</name>
</author><author><name sortKey="Davis, T L" sort="Davis, T L" uniqKey="Davis T" first="T. L." last="Davis">T. L. Davis</name>
</author><author><name sortKey="Feerari, R" sort="Feerari, R" uniqKey="Feerari R" first="R." last="Feerari">R. Feerari</name>
</author><author><name sortKey="Gillespie, M" sort="Gillespie, M" uniqKey="Gillespie M" first="M." last="Gillespie">M. Gillespie</name>
</author><author><name sortKey="Chase, T N" sort="Chase, T N" uniqKey="Chase T" first="T. N." last="Chase">T. N. Chase</name>
</author><series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="1992">1992</date>
</imprint><seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Age</term>
<term>Chemotherapy</term>
<term>Dopamine agonist</term>
<term>Exploration</term>
<term>Human</term>
<term>Mitochondria</term>
<term>Oxygen consumption</term>
<term>Parkinson disease</term>
<term>Platelet</term>
<term>Respiratory chain</term>
<term>Treatment</term>
</keywords><keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Exploration</term>
<term>Traitement</term>
<term>Homme</term>
<term>Age</term>
<term>Consommation oxygène</term>
<term>Chimiothérapie</term>
<term>Stimulant dopaminergique</term>
<term>Mitochondrie</term>
<term>Thrombocyte</term>
<term>Chaîne respiratoire</term>
</keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01><fA03 i2="1"><s0>Mov. disord.</s0>
</fA03><fA08 i1="01" i2="1" l="ENG"><s1>Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease</s1>
</fA08><fA11 i1="01" i2="1"><s1>BRAVI (D.)</s1>
</fA11><fA11 i1="02" i2="1"><s1>ANDERSON (J. J.)</s1>
</fA11><fA11 i1="03" i2="1"><s1>DAGANI (F.)</s1>
</fA11><fA11 i1="04" i2="1"><s1>DAVIS (T. L.)</s1>
</fA11><fA11 i1="05" i2="1"><s1>FEERARI (R.)</s1>
</fA11><fA11 i1="06" i2="1"><s1>GILLESPIE (M.)</s1>
</fA11><fA11 i1="07" i2="1"><s1>CHASE (T. N.)</s1>
</fA11><fA14 i1="01"><s1>NINDS NIH, experimental therapeutics branch</s1>
<s2>Bethesda MD 20892</s2>
<s3>USA</s3>
</fA14><fA20><s1>228-231</s1>
</fA20><fA21><s1>1992</s1>
</fA21><fA23 i1="01"><s0>ENG</s0>
</fA23><fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000028971070060</s5>
</fA43><fA44><s0>0000</s0>
</fA44><fA45><s0>24 ref.</s0>
</fA45><fA47 i1="01" i2="1"><s0>92-0467065</s0>
</fA47><fA64 i2="1"><s0>Movement disorders</s0>
</fA64><fA66 i1="01"><s0>USA</s0>
</fA66><fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02><fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
</fC03><fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
</fC03><fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
</fC03><fC03 i1="02" i2="X" l="FRE"><s0>Exploration</s0>
</fC03><fC03 i1="02" i2="X" l="ENG"><s0>Exploration</s0>
</fC03><fC03 i1="02" i2="X" l="SPA"><s0>Exploración</s0>
</fC03><fC03 i1="03" i2="X" l="FRE"><s0>Traitement</s0>
</fC03><fC03 i1="03" i2="X" l="ENG"><s0>Treatment</s0>
</fC03><fC03 i1="03" i2="X" l="GER"><s0>Aufbereiten</s0>
</fC03><fC03 i1="03" i2="X" l="SPA"><s0>Tratamiento</s0>
</fC03><fC03 i1="04" i2="X" l="FRE"><s0>Homme</s0>
</fC03><fC03 i1="04" i2="X" l="ENG"><s0>Human</s0>
</fC03><fC03 i1="04" i2="X" l="SPA"><s0>Hombre</s0>
</fC03><fC03 i1="05" i2="X" l="FRE"><s0>Age</s0>
</fC03><fC03 i1="05" i2="X" l="ENG"><s0>Age</s0>
</fC03><fC03 i1="05" i2="X" l="SPA"><s0>Edad</s0>
</fC03><fC03 i1="06" i2="X" l="FRE"><s0>Consommation oxygène</s0>
</fC03><fC03 i1="06" i2="X" l="ENG"><s0>Oxygen consumption</s0>
</fC03><fC03 i1="06" i2="X" l="SPA"><s0>Consumo oxígeno</s0>
</fC03><fC03 i1="07" i2="X" l="FRE"><s0>Chimiothérapie</s0>
</fC03><fC03 i1="07" i2="X" l="ENG"><s0>Chemotherapy</s0>
</fC03><fC03 i1="07" i2="X" l="SPA"><s0>Quimioterapia</s0>
</fC03><fC03 i1="08" i2="X" l="FRE"><s0>Stimulant dopaminergique</s0>
</fC03><fC03 i1="08" i2="X" l="ENG"><s0>Dopamine agonist</s0>
</fC03><fC03 i1="08" i2="X" l="SPA"><s0>Estimulante dopaminérgico</s0>
</fC03><fC03 i1="09" i2="X" l="FRE"><s0>Mitochondrie</s0>
</fC03><fC03 i1="09" i2="X" l="ENG"><s0>Mitochondria</s0>
</fC03><fC03 i1="09" i2="X" l="SPA"><s0>Mitocondria</s0>
</fC03><fC03 i1="10" i2="X" l="FRE"><s0>Thrombocyte</s0>
</fC03><fC03 i1="10" i2="X" l="ENG"><s0>Platelet</s0>
</fC03><fC03 i1="10" i2="X" l="SPA"><s0>Trombocito</s0>
</fC03><fC03 i1="11" i2="X" l="FRE"><s0>Chaîne respiratoire</s0>
</fC03><fC03 i1="11" i2="X" l="ENG"><s0>Respiratory chain</s0>
</fC03><fC03 i1="11" i2="X" l="SPA"><s0>Cadena respiratoria</s0>
</fC03><fC07 i1="01" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
</fC07><fC07 i1="01" i2="X" l="ENG"><s0>Nervous system diseases</s0>
</fC07><fC07 i1="01" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
</fC07><fN21><s1>275</s1>
</fN21>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F99 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 002F99 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Curation
|type= RBID
|clé= Pascal:92-0467065
|texte= Effect of aging and dopaminomimetic therapy on mitochondrial respiratory function in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 |  |
